How many insider trades does FilingIQ track for MAIA?

FilingIQ tracks 174 Form 4 insider transactions for MAIA (MAIA Biotechnology, Inc.), covering filings from Jul 28, 2022 onwards. 15 of those were filed in the last 90 days.

Are MAIA insiders net buyers or net sellers?

Across the full Form 4 history for MAIA, 145 transactions (83%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does MAIA insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is MAIA in?

MAIA Biotechnology, Inc. (MAIA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $79.04M.

MAIA insider trading

NYSE American Healthcare

MAIA Biotechnology, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

174

Last 90 days

Buys / sells

83% / 0%

Market cap

$79.04M

About MAIA Biotechnology, Inc.

MAIA Biotechnology, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the development of targeted immunotherapies for cancer. Its lead product Ateganosine, a telomere-targeting agent currently in clinical development to evaluate its activity in Non-Small Cell Lung Cancer (NSCLC). The company was incorporated in 2018 and is headquartered in Chicago, Illinois.

Company website: maiabiotech.com

MAIA insider activity at a glance

FilingIQ has scored 174 insider transactions for MAIA since Jul 28, 2022. The most recent filing in our index is dated Jun 1, 2026.

Across the full history, 145 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on MAIA insider trades is 48.2/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live MAIA trades on FilingIQ Raw filings on SEC EDGAR

Latest MAIA Form 4 filings

Vitoc Vlad Chief Executive Officer

P Jun 1, 2026

Vitoc Vlad Chief Executive Officer

P Nov 28, 2025

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,165

UNITED THERAPEUTICS Corp

APLS 275

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

GH 191

Guardant Health, Inc.

KYMR 178

Kymera Therapeutics, Inc.

First Tracks Biotherapeutics, Inc.

Frequently asked

How many insider trades does FilingIQ track for MAIA?: FilingIQ tracks 174 Form 4 insider transactions for MAIA (MAIA Biotechnology, Inc.), covering filings from Jul 28, 2022 onwards. 15 of those were filed in the last 90 days.
Are MAIA insiders net buyers or net sellers?: Across the full Form 4 history for MAIA, 145 transactions (83%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does MAIA insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is MAIA in?: MAIA Biotechnology, Inc. (MAIA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $79.04M.

Methodology & sources

Every MAIA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.